References
- Annola K, Keski-Rahkonen P, Vähäkangas K, et al. (2008). Simultaneous determination of acrylamide, its metabolite glycidamide and antipyrine in human placental perfusion fluid and placental tissue by liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 876:191–7
- Baum M, Fauth E, Fritzen S, et al. (2005a). Acrylamide and glycidamide: genotoxic effects in V79-cells and human blood. Mutat Res 580:61–9
- Baum M, Fauth E, Fritzen S, et al. (2005b). Acrylamide and glycidamide: approach towards risk assessment based on biomarker guided dosimetry of genotoxic/mutagenic effects in human blood. Adv Exp Med Biol 561:77–88
- Berger FI, Feld J, Bertow D, et al. (2011). Biological effects of acrylamide after daily ingestion of various foods in comparison to water: a study in rats. Mol Nutr Food Res 55:387–99
- Boettcher MI, Angerer J. (2005). Determination of the major mercapturic acids of acrylamide and glycidamide in human urine by LC-ESI-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 824:283–94
- Boettcher MI, Bolt HM, Drexler H, et al. (2006). Excretion of mercapturic acids of acrylamide and glycidamide in human urine after single oral administration of deuterium-labelled acrylamide. Arch Toxicol 80:55–61
- Brady JF, Ishizaki H, Fukuto JM, et al. (1991). Inhibition of cytochrome-P-450 2e1 by diallyl sulfide and its metabolites. Chem Res Toxicol 4:642–7
- Doerge DR, da Costa GG, McDaniel LP, et al. (2005). DNA adducts derived from administration of acrylamide and glycidamide to mice and rats. Mutat Res 580:131–41
- Doroshyenko O, Fuhr U, Kunz D, et al. (2009). In vivo role of cytochrome P450 2E1 and glutathione-S-transferase activity for acrylamide toxicokinetics in humans. Cancer Epidemiol Biomarkers Prev 18:433–43
- Fennell TR, Sumner SC, Snyder RW, et al. (2005). Metabolism and hemoglobin adduct formation of acrylamide in humans. Toxicol Sci 85:447–59
- Friedman, M. (2003). Chemistry, biochemistry, and safety of acrylamide. A review. J Agric Food Chem 51:4504–26
- Friedman MA, Dulak LH, Stedham MA, et al. (1995). A lifetime oncogenicity study in rats with acrylamide. Fundam Appl Toxicol 27:95–105
- Fuhr U, Boettcher MI, Kinzig- Schippers M, et al. (2006). Toxicokinetics of acrylamide in humans after ingestion of a defined dose in a test meal to improve risk assessment for acrylamide carcinogenicity. Cancer Epidemiol Biomarkers Prev 15:266–71
- Fuhr U, Wolff T, Harder S, et al. (1990). Quinolone inhibition of cytochrome P-450-dependent caffeine metabolism in human liver microsomes. Drug Metab Dispos 18:1005–10
- Fullerton PM, Barnes J. (1966). Peripheral neuropathy in rats produced by acrylamide. Br J Ind Med 23:210–21
- Ghanayem BI, McDaniel LP, Churchwell MI, et al. (2005). Role of CYP2E1 in the epoxidation of acrylamide to glycidamide and formation of DNA and hemoglobin adducts. Toxicol Sci 88:311–18
- Granvogl M, Koehler P, Latzer L, et al. (2008). Development of a stable isotope dilution assay for the quantitation of glycidamide and its application to foods and model systems. J Agric Food Chem 56:6087–92
- Guengerich FP, Kim DH, Iwasaki M, et al. (1991). Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol 4:168–79
- Hashimoto K, Tanii H. (1985). Mutagenicity of acrylamide and its analogues in Salmonella typhimurium. Mutat Res 158:129–33
- Hogervorst JG, Schouten LJ, Konings EJ, et al. (2007). A prospective study of dietary acrylamide intake and the risk of endometrial ovarian, and breast cancer. Cancer Epidemiol Biomarkers 16:2304–13
- Hogervorst JG, Schouten LJ, Konings EJ, et al. (2008). Dietary acrylamide intake and the risk of renal cell, bladder, and prostate cancer. Am J Clin Nutr 87:1428–38
- International Agency for Research on Cancer (IARC) (1994). Monographs on the evaluation of carcinogenic risks to humans. Some industrial chemicals. IARC 60:389–433
- Kirman CR, Gargas ML, Deskin R, et al. (2003). A physiologically based pharmacokinetic model for acrylamide and its metabolite, glycidamide, in the rat. J Toxicol Environ Health A 66:253–74
- Klaunig, J.E. (2008). Acrylamide carcinogenicity. J Agric Food Chem 56:5984–8
- Mei N, Hu J, Churchwell MI, et al. (2008). Genotoxic effects of acrylamide and glycidamide in mouse lymphoma cells. Food Chem Toxicol 46:628–36
- Motwani HV, Tornqvist M. (2011). Quantitative analysis by liquid chromatography-tandem mass spectrometry of glycidamide using the cob(I)alamin trapping method: validation and application to in vitro metabolism of acrylamide. J Chromatogr A 1218:4389–94
- Mucci LA, Dickman PW, Steineck G, et al. (2003). Dietary acrylamide and cancer of the large bowel, kidney, and bladder: absence of an association in a population-based study in Sweden. Br J Cancer 88:84–9
- Murphy MP. (2009). How mitochondria produce reactive oxygen species. Biochem J 417:1–13
- Olesen PT, Olsen A, Frandsen H, et al. (2008). Acrylamide exposure and incidence of breast cancer among postmenopausal women in the Danish Diet, Cancer and Health study. Int J Cancer Suppl 122:2094–100
- Oneta CM, Lieber CS, Li J, et al. (2002). Dynamics of cytochrome P4502E1 activity in man: induction by ethanol and disappearance during withdrawal phase. J Hepatol 36:47–52
- Puppel N, Tjaden Z, Fueller F, et al. (2005). DNA strand breaking capacity of acrylamide and glycidamide in mammalian cells. Mutat Res 580:71–80
- Rokitta D, Fuhr U. (2010). Comparison of enzyme kinetic parameters obtained in vitro for reactions mediated by human CYP2C enzymes including major CYP2C9 variants. Curr Drug Metab 11:153–61
- Segerback D, Calleman CJ, Schroeder JL, et al. (1995). Formation of N-7-(2-carbamoyl-2-hydroxyethyl)guanine in DNA of the mouse and the rat following intraperitoneal administration of [14C]acrylamide. Carcinogenesis 16:1161–5
- Settels E, Bernauer U, Palavinskas R, et al. (2008). Human CYP2E1 mediates the formation of glycidamide from acrylamide. Arch Toxicol 82:717–27
- Sorgel F, Weissenbacher R, Kinzig-Schippers M, et al. (2002). Acrylamide: increased concentrations in homemade food and first evidence of its variable absorption from food, variable metabolism and placental and breast milk transfer in humans. Chemotherapy 48:267–74
- Sumner SC, Selvaraj L, Nauhaus SK, et al. (1999). Role of cytochrome P450 2E1 in the metabolism of acrylamide and acrylonitrile in mice. Chem Res Toxicol 12:1110–16
- Sweeney LM, Kirman CR, Gargas ML, et al. (2010). Development of a physiologically-based toxicokinetic model of acrylamide and glycidamide in rats and humans. Food Chem Toxicol 48:668–85
- Takahashi M, Ohara T, Hashimoto K, et al. (1971). Electrophysiological study of nerve injuries in workers handling acrylamide. Int Arch Arbeitsmed 28:1–11
- Tareke E, Rydberg P, Karlsson P, et al. (2002). Analysis of acrylamide, a carcinogen formed in heated foodstuffs. J Agric Food Chem 50:4998–5006
- Taubert D, Glöckner R, Müller D, et al. (2006). The garlic ingredient diallyl sulfide inhibits cytochrome P450 2E1 dependent bioactivation of acrylamide to glycidamide. Toxicol Lett 164:1–5
- Tornqvist M, Paulsson B, Vikström AC, et al. (2008). Approach for cancer risk estimation of acrylamide in food on the basis of animal cancer tests and in vivo dosimetry. J Agric Food Chem 56:6004–12
- Umeda S, Harakawa N, Yamamoto M, et al. (2005). Effect of nonspecific binding to microsomes and metabolic elimination of buprenorphine on the inhibition of cytochrome P4502D6. Biol Pharm Bull 28:212–16